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ABSTRACT
Horner’s syndrome is classically characterized by a
triad of miosis, partial ptosis and anhidrosis. The
etiology is due to an interruption in the sympathetic
innervation to the eye. A prompt diagnosis is crucial,
given that Horner’s syndrome could be a manifesta-
tion of a life-threatening condition. A thorough case
history and clinical evaluation must be employed to
arrive at the diagnosis. An important means for
confirming Horner’s syndrome is pharmacological
testing, which is also used to localize the level where
the sympathetic chain is compromised. Following the
diagnosis and localization of the lesion, an algorithm
should be followed to determine the testing indicated,
in order to ascertain the underlying cause of the
condition. There is a known association between
mediastinal neuroblastoma and preganglionic
Horner’s syndrome. 
We present a case of a seven-year-old boy with a
history of excision of a mediastinal neuroblastoma
at age two, who soon after presented with signs
and symptoms associated with a residual Horner’s
syndrome.
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CASE REPORT
A seven-year-old Caucasian male was referred to the Neuro-
Ophthalmology Service for evaluation of a suspected left
Horner’s syndrome. Six days prior to the consult exam, the
patient was seen at an optometrist’s office with complaints
of bilateral, constant, blurred vision and headaches. The
child’s parents felt the headaches were caused by school
related activities and had been occurring on an intermittent
basis for approximately one month. 
The patient had an unremarkable ocular history
except for prior discovery of anisocoria. The patient’s
medical history included excision of a mediastinal
neuroblastoma. The patient initially presented to his
pediatrician at age two, with a persistent cough, and was
diagnosed with presumptive pneumonia. Given no
response to antibiotics, a chest x-ray (CXR) was
performed showing a mediastinal shadow. This CXR
prompted referral to a local children’s hospital, where a
computed tomography (CT) of the thorax confirmed a
mediastinal mass (Fig. 1A,B). The lesion was excised
and histopathology revealed a neuroblastoma. The
pediatrician noted a left Horner’s syndrome while the
patient was hospitalized, which was attributed to the
neuroblastoma. The child was compliant with scheduled
follow-ups until age five, during which time there were no
new symptoms and no recurrences. 
The family ocular history revealed macular
degeneration in a paternal great-grandmother and the
family medical history was unremarkable. The patient
was not using any medications, but was allergic to
penicillin. The mother reported that he was one of the
triplets born at 34 weeks and 4 days gestation.
A review of the patient’s prior ophthalmic records
disclosed best corrected visual acuities of 6/7.5 (20/25) at
distance and 6/9 (20/30) at near in each eye, with a high
hyperopic refractive error. Cover tests at distance and near
were orthophoric horizontally and vertically. Confrontation
fields and ocular motility were normal. Pupil size in the
light was 5 mm OD and 3 mm OS; in the dark, the pupils
measured 7 mm OD and 4 mm OS. Direct and consensual
responses were reactive and no afferent pupillary defect
(APD) was detected in either eye. Slit lamp exam was
unremarkable and was negative for iris heterochromia.
Intraocular pressures (IOPs) were 13 mmHg OD and 11
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described as having indistinct borders and appeared to be
slightly elevated. The referring doctor’s assessment
consisted of anisocoria, left Horner’s syndrome, and
indistinct discs with questionable edema. The plan was to
refer to a neuro-ophthalmologist for evaluation of
Horner’s syndrome and for further investigation of the
patients’ complaints of headaches.
At the neuro-ophthalmological consult, visual
acuities were unchanged, but cover tests showed a
comitant esophoria at distant and near. There were no
extra ocular movement (EOM) restrictions. The pupil
exam confirmed anisocoria, greater in the dark, with no
RAPD; a dilation lag was noted for the left pupil. Other
pertinent findings included normal IOPs, no cranial nerve
abnormalities, and no iris heterochromia. Goldmann
visual fields were unremarkable with no hemianopia.
Optical coherence tomography (OCT) showed slight
increased thickness of the nerve fiber layer (Fig. 2). There
were no nerve fiber bundle defects or macular edema in
either eye. Fundoscopy revealed no retinopathy or
maculopathy and a spontaneous venous pulsation was
observed in each eye. Fundus photos documented
crowded discs, likely related to hyperopia (Fig. 3).
In this particular case, it was concluded that
pharmacological testing was not necessary, as Horner’s
syndrome had been described since age two and was
likely related to the mediastinal neuroblastoma. The
patient was sent to a pediatric neurologist for a headache
evaluation, given the patient’s history of neuroblastoma.
A magnetic resonance imaging (MRI) of the brain was
unremarkable, as was a chest CT. The patient was given a
new prescription for glasses, as well as topiramate for the
headaches, which according to the patient’s parents,
improved both the incidence and severity of his
symptoms.
A B
Fig. 1 (A, B) Computed tomography (CT) of the thorax shows the presence of a mediastinal mass. Anatomic relations are indicated in the figures.
Fig. 2 Optical coherence tomography (OCT) showed slight increased thick-
ness of the nerve fiber layer. There were no nerve fiber bundle defects.
mmHg OS measured with non-contact tonometry.
A dilated fundus examination showed a normal vitreous,
macula, and no retinopathy. A C/D ratio of 0.20 was
estimated in both eyes; however, the optic discs were
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DISCUSSION
Neuroblastoma is a tumor that arises from neuroblasts in
the sympathetic nervous system.1 It is the most common
extracranial solid tumor of childhood.2 The most frequent
sites include the adrenal medulla (60%), retroperitoneal
cavity (20%) and mediastinum (10%).1 Peak incidence
occurs in children younger than two, with prognosis
typically worsening with increasing age.1,2 The stage of
the tumor at diagnosis is equally important to the
prognosis, which can have variable courses.1 Neuro-
blastomas may regress spontaneously (Stage 4s), may
mature to benign ganglioneuromas, or may result in a
fatal outcome.1 Therefore, it is critical to identify
symptoms and signs that may lead to diagnosis and
appropriate treatment. Non-specific symptoms include
weight loss, lethargy, poor feeding and fever, while more
specific and local ophthalmic signs may involve pro-
ptosis, ecchymosis, and Horner’s syndrome.3 Eye care
providers may be the first professional that a patient
consults and could play a pivotal role in the diagnosis. 
Horner’s syndrome results from an interruption in the
oculosympathetic pathway, composed of three neurons.4
The first neuron, termed central, starts at the hypothalamus
and descends to the first synapse at the ciliospinal center
of Budge (C8-T2).5 The second neuron, or preganglionic
neuron, exits out of the T1 root, courses over the apex of
the lung and synapses at the superior cervical ganglion.5
Finally, the third neuron, postganglionic, leaves the
superior cervical ganglion and ascends back via the
internal carotid artery to the cavernous sinus.5 From
the cavernous sinus, sympathetic branches travel beside
the abducens nerve to the ophthalmic division of the
trigeminal nerve prior to stimulating the iris dilator and
Muller’s muscles5 (Fig. 4).
Any portion of the sympathetic pathway can be
affected and give rise to Horner’s syndrome. While
congenital Horner’s is likely to result from birth trauma,
most causes are due to acquired conditions.6 A lesion
within the first neuron will usually result from strokes,
demyelinating diseases, and neoplasms.6,7 Second order
neuron lesions are related to a Pancoast tumor at the apex
of the lung, as well neuroblastoma or thyroid tumors.6,7
Lastly, lesions affecting the third neuron are generally
associated with dissection of the internal carotid artery
and cluster headaches.6,7
Thus, Horner’s syndrome is a sign of a separate
condition and as listed previously, the underlying disorder
may be relatively benign or be potentially life threatening.
The disorder can be difficult to detect because patients are
typically asymptomatic of vision loss. Therefore, it is
important to recognize the signs and symptoms associated
with the condition. A triad of ipsilateral miosis, partial
ptosis, and anhidrosis characterizes Horner’s syndrome.
Miosis and ptosis are the most common signs, while
anhidrosis is seen occasionally.6 Other signs may include
dilation lag, iris heterochromia, enophthalmos, and
reverse ptosis.3,6
The anisocoria in Horner’s syndrome must be
differentiated from a physiological anisocoria. Horner’s
patients will show the greatest amount of anisocoria in the
dark.5 A dilation lag test is the simplest way to distinguish
between the two. A normal pupil will fully dilate soon
after a light stimulus is extinguished. A Horner’s affected
pupil, however, will take nearly five seconds to begin
dilating.5
To validate whether a patient has Horner’s syndrome,
topical pharmacological agents may be used, which may
include 2% to 10% cocaine or 0.5% to 1% apraclonidine.8
A B
Fig. 3 Fundus photos documented crowded discs likely related to hyperopia in (A) right eye and (B) left eye. Optic nerve head edema was not noted in either eye.
Once Horner’s syndrome has been confirmed, it is
critical to localize the lesion causing the condition. One
percent hydroxyamphetamine (Paredrine) is used to
detect postganglionic Horner’s.8 Hydroxyamphetamine
stimulates the release of norepinephrine from presynaptic
postganglionic nerve terminals.8 When instilled, dilation
of a Horner’s pupil will point to a central or preganglionic
lesion because the postganglionic neuron is still intact to
release norepinephrine.8 A postganglionic lesion will
result in little to no norepinephrine release and incomplete
to absent dilation.8
Imaging is crucial, in conjunction with appropriate
medical and/or surgical consultation, depending on the
localization and suspected etiology. MRI of the brain and
spine may be required for central and preganglionic
lesions.10 Contrasted CT or MR scans are sufficient for
preganglionic lesions in the lung, mediastinum or neck.11,12
Finally, MRI/MRA or CTA of the neck is needed if a
postganglionic lesion is diagnosed and carotid dissection
is suspected, as dissection is a major cause of stroke in
young people.11  
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Fig. 4 Diagram of the sympathetic pathway showing the location of first,
second and third order neuron. [Courtesy of: Dr. Tang and Dr. Hayman].
Cocaine inhibits the re-uptake of norepinephrine and as a 
result, norepinephrine accumulates in the synaptic cleft 
and stimulates the dilator muscle in normal pupils.8 A 
Horner’s syndrome pupil however, will fail to dilate 
because of lack of norepinephrine in the cleft. Cocaine is 
highly effective in the diagnostic process, but patient 
scheduling and availability are major deterrents in its use. 
Currently, cocaine is primarily used in infants of one year 
or younger, where apraclonidine is not advised due to the 
risk of causing dysautonomia.9 In most patients however, 
apraclonidine (Iopidine), a weak alpha-1 agonist and 
strong alpha-2 agonist, can be used and has an opposite 
effect to cocaine. In Horner’s syndrome, there is an 
up-regulation of alpha-1 receptors in response to sympa-
thetic denervation, leading to super sensitivity for 
apraclonidine.8,9 A reversal of miosis and lid elevation 
of the Horner’s affected side with little to no effect on 
the normal pupil is observed with its instillation.8,9 
A slight drawback to apraclonidine is that up-regulation 
of alpha-1 receptors takes between 5 to 8 days to develop, 
which could lead to false negative findings in Horner’s 
before one week of onset.9
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